UA112984C2 - COMPOSITION OF ANTI-α4β7 ANTIBODY - Google Patents
COMPOSITION OF ANTI-α4β7 ANTIBODYInfo
- Publication number
- UA112984C2 UA112984C2 UAA201313902A UAA201313902A UA112984C2 UA 112984 C2 UA112984 C2 UA 112984C2 UA A201313902 A UAA201313902 A UA A201313902A UA A201313902 A UAA201313902 A UA A201313902A UA 112984 C2 UA112984 C2 UA 112984C2
- Authority
- UA
- Ukraine
- Prior art keywords
- antibodies
- antibody
- antibody compositions
- composition
- compositions
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Описані композиції антитіл, що включають суміш анти-α4β7 антитіла, антиоксиданту або хелатуючого агента і щонайменше однієї вільної амінокислоти. Розкриті композиції можуть мати покращену стабільністю, знижене утворенням агрегатів або обидві ці характеристики. Даний винахід додатково передбачає безпечний режим дозування таких композицій антитіл, якого можна легко дотримуватися і який забезпечує терапевтично ефективну кількість анти-α4β7 антитіла in vivo.Antibody compositions comprising a mixture of anti-α4β7 antibodies, an antioxidant or a chelating agent and at least one free amino acid are described. The disclosed compositions may have improved stability, reduced aggregate formation, or both. The present invention further provides a safe dosage regimen for such readily observable antibody compositions that provides a therapeutically effective amount of anti-α4β7 antibodies in vivo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161481522P | 2011-05-02 | 2011-05-02 | |
| PCT/US2012/036069 WO2012151247A2 (en) | 2011-05-02 | 2012-05-02 | FORMULATION FOR ANTI-α4β7 ANTIBODY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA112984C2 true UA112984C2 (en) | 2016-11-25 |
Family
ID=57792056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201313902A UA112984C2 (en) | 2011-05-02 | 2012-02-05 | COMPOSITION OF ANTI-α4β7 ANTIBODY |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR122749A2 (en) |
| UA (1) | UA112984C2 (en) |
-
2012
- 2012-02-05 UA UAA201313902A patent/UA112984C2/en unknown
-
2021
- 2021-06-25 AR ARP210101761A patent/AR122749A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR122749A2 (en) | 2022-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201391613A1 (en) | COMPOSITION ANTI-α4β7 ANTIBODIES | |
| PH12020500336A1 (en) | FORMULATION FOR ANTI-a4á7 ANTIBODY | |
| CY1121419T1 (en) | INHIBITION OF FUCOSYLING OF PROTEINS IN VIVO USING FUCOCZE PROPORTIONS | |
| EA201390145A1 (en) | CONJUGATES, PARTICLES, COMPOSITIONS AND RELATED METHODS | |
| EA201491644A1 (en) | PHARMACEUTICAL COMPOSITIONS | |
| EA201691590A1 (en) | BENZIMIDAZOL-2-AMINES AS MIDHI INHIBITORS | |
| EA201171414A1 (en) | IAP FAMILY INHIBITORS | |
| MX2019012375A (en) | Lfa-1 inhibitor formulations. | |
| PL401632A1 (en) | Pharmaceutical composition comprising an ACE inhibitor and a calcium channel blocker, a method for its preparation and the dosage unit comprising the composition | |
| UA112984C2 (en) | COMPOSITION OF ANTI-α4β7 ANTIBODY | |
| EA201990056A1 (en) | COMPOSITION ANTI-α4β7 ANTIBODIES | |
| EA201992881A3 (en) | ANTI-47 ANTIBODY COMPOSITION | |
| TW202434293A (en) | Formulation for anti-α4β7 antibody | |
| NZ740726A (en) | Compounds for treating the remyelination blockade in diseases associated with the expression of herv-w envelope protein | |
| ECSP13013059A (en) | FORMULATION FOR ANTIBODY ANTI- 4 7 |